IVF Services Global Market Report 2024

The ivf services market size has grown rapidly in recent years. It will grow from $17.13 billion in 2023 to $19.07 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The expansion observed in the historical period can be attributed to factors such as the increasing prevalence of polycystic ovary syndrome (PCOS), a rise in cases of premature ovarian failure, an increasing rate of male infertility, and insurance coverage for IVF procedures.

The ivf services market size is expected to see strong growth in the next few years. It will grow to $27.67 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period can be attributed to factors such as the rising infertility rate, technological developments in fertility treatment, a growing adoption of IVF services to aid in pregnancy, an increasing number of same-sex couples, a rise in the number of fertility clinics, an increase in disposable income, and late parenthood. Major trends expected in the forecast period include providing mitochondrial replacement therapies to potentially overcome genetic disorders, adopting new technologies such as fertility freezing to offer better solutions to individuals seeking fertility treatments, offering preimplantation genetic testing for aneuploidy (PGT-A) screening to potentially increase the chances of pregnancy, using artificial intelligence to reduce costs and time, implementing blockchain-based apps to curate data for users, and adopting advanced technologies such as time-lapse microscopy for safe, uninterrupted, and constant embryo observation.

The growth of the in vitro fertilization (IVF) services market is attributed to the increasing infertility rate. Infertility, defined as the inability to conceive within 12 months, affects around 12 to 13 couples in 100, according to the US Department of Health and Human Services. The Indian Journal of Community Medicine reports 15 to 20 million infertility cases in India alone. This rise in infertility has led individuals to turn to IVF services, contributing to the expansion of the market.

Government initiatives aimed at improving access to fertility treatments are expected to drive the growth of the IVF services market. Governments are undertaking specific actions, policies, or projects to address fertility-related issues. An example is the New South Wales Affordable IVF Program, where the New South Wales government committed $80 million from 2022-23 to 2025-26 to enhance access to affordable fertility treatments.

The application of platelet-rich plasma (PRP) is a recent technique increasingly employed to enhance the success rate of IVF, particularly in patients with recurrent implantation failures. PRP is utilized alongside IVF to improve egg quality, uterine lining thickness, and endometrial receptivity, primarily for cases of recurrent implantation failure. Studies show that women treated with PRP experience significant improvements in Follicle-Stimulating Hormone (FSH), Anti-Müllerian Hormone (AMH), and Antral Follicle Count (AFC), thereby aiding fertility.

Major companies in the IVF services sector are innovating by incorporating artificial intelligence (AI) into IVF treatments. The use of AI in IVF has the potential to transform fertility care by providing personalized, data-driven insights for clinicians and patients. For instance, Alife Health, a US-based healthcare company, launched new artificial intelligence software in October 2022 to advance IVF treatment outcomes, reduce costs, and support clinical decision-making during crucial stages of the IVF process.

In July 2023, BPEA EQT, a Hong Kong-based investment company, acquired a 60% stake in Indira IVF for approximately $657 million. This strategic move aims to strengthen Indira IVF's presence across India, explore expansion into neighboring markets, and enhance accessibility to fertility services and reproductive health for couples. Indira IVF is an India-based company specializing in providing IVF services.

Major companies operating in the ivf services market report are Monash IVF Group, Virtus Health Limited, Chelsea and Westminster Hospital NHS Foundation Trust, Genea Limited, Boston IVF, IVF Spain, Morpheus Life Sciences Pvt. Ltd., Dünya IVF, Cardone Reproductive Medicine & Infertility LLC, Cloudnine Fertility, Sun Pharmaceuticals Industries Ltd., Cadila Healthcare Ltd., Trivector Origio Scientific, Lab IVF Asia Pte Ltd., LG Life Sciences, Bourn Hall Clinic, Southend Fertility, Indira IVF, Pearl Women Hospital & Yash IVF Center, Corion Fertility Clinic, Origin International Fertility Center, Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, , Bloom Fertility and Healthcare, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, United Family Healthcare, The New Hope Fertility Center, Melinda Hospital, Bocah Indonesia, Daya Medika, Clinique de la Muette, Klinikum Stuttgart, DRK Kliniken Berlin, University Medical Center Freiburg, CREATE Fertility, The Centre for Reproductive & Genetic Health, The Bridge Centre, Next Generation Clinic, UNICA Clinic – Prague, Repromeda s.r.o., MD Medical Group, Univfy, Progyny, Advantia Health, Maven Clinic, Future Family, Instituto de Fertilidad Humana, The Colombian Center for Fertility and Sterility, NMC Health, Dubai Gynecology and Fertility Centre, , New Life Medical Centre, Cairo Fertility Centre (Egypt), Queens Fertility Centre (Egypt), BPE Partners, Cleopatra Hospitals Group (CHG)

Western Europe was the largest region in the IVF services market in 2023. North America was the second largest region in global IVF services market share. The regions covered in the ivf services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ivf services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The main types of cycles in the IVF services market are fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. A fresh IVF cycle is completed using eggs and embryos that have never been frozen. In this process, eggs are extracted and fertilized in the laboratory with semen. Various service providers in the IVF services market include fertility clinics, hospitals, surgical centers, and clinical research institutes. These services find applications in sectors such as fertility clinics, hospitals, and other healthcare settings.

The IVF services market research report is one of a series of new reports that provides IVF services market statistics, including IVF services industry global market size, regional shares, competitors with an IVF services market share, detailed IVF services market segments, market trends and opportunities, and any further data you may need to thrive in the IVF services industry. This IVF services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The IVF services market includes revenues earned by entities by providing services such as conventional insemination services, and intracytoplasmic sperm injection services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.